View in EDS HTML Full Text PDF Full Text

Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.

Saved in:
Bibliographic Details
Title: Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.
Authors: Agnarelli A; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Mitchell S; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Caalim G; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Wood CD; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Milton-Harris L; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Chevassut T; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., West MJ; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK., Mancini EJ; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.
Source: Hematological oncology [Hematol Oncol] 2022 Aug; Vol. 40 (3), pp. 417-429. Date of Electronic Publication: 2022 May 18.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35544413
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agnarelli+A%22">Agnarelli A</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Mitchell+S%22">Mitchell S</searchLink>; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Caalim+G%22">Caalim G</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Wood+CD%22">Wood CD</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Milton-Harris+L%22">Milton-Harris L</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Chevassut+T%22">Chevassut T</searchLink>; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22West+MJ%22">West MJ</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Mancini+EJ%22">Mancini EJ</searchLink>; Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Brighton, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> [Hematol Oncol] 2022 Aug; Vol. 40 (3), pp. 417-429. <i>Date of Electronic Publication: </i>2022 May 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8307268 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-1069 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202780232%22">02780232 </searchLink><i>NLM ISO Abbreviation: </i>Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35544413
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hon.3016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 417
    Titles:
      – TitleFull: Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agnarelli A
      – PersonEntity:
          Name:
            NameFull: Mitchell S
      – PersonEntity:
          Name:
            NameFull: Caalim G
      – PersonEntity:
          Name:
            NameFull: Wood CD
      – PersonEntity:
          Name:
            NameFull: Milton-Harris L
      – PersonEntity:
          Name:
            NameFull: Chevassut T
      – PersonEntity:
          Name:
            NameFull: West MJ
      – PersonEntity:
          Name:
            NameFull: Mancini EJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1099-1069
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Hematological oncology
              Type: main
ResultId 1